Abstract
The article is devoted to the issues of etiology, pathogenesis, classification, basic approaches to the diagnosis and treatment of infectious-toxic shock. Despite progress in studying the pathophysiology of sepsis and the development of new antibacterial drugs, mortality from endotoxic shock remains high. In recent years, antishock vaccines have been actively developed, but they have not yet received widespread use in clinical practice. The introduction of these drugs in the future may contribute to the survival of patients with various pathologies, as well as those in the “shock” risk group (military, emergency services personnel, etc.).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
